This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Georgia Research Foundation Inc. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Cancer Treatment: The Work of Joshua Choi
Introduction
Joshua Choi is an innovative inventor based in Athens, GA (US). He has made significant contributions to the field of therapeutic technology, particularly in the area of cancer treatment. His work focuses on combining photodynamic therapy with immune-stimulating techniques to enhance the effectiveness of cancer treatments.
Latest Patents
Joshua Choi holds a patent for "Immune-stimulating photoactive hybrid nanoparticles." This patent describes a therapeutic technology that merges the phototoxic and immune-stimulating capabilities of photodynamic therapy with the immune system's effectiveness. The goal is to reduce the viability of cancer cells and tumors. The nanoparticle compositions combine an immunostimulant with a photosensitizer using a nanoparticle delivery platform. For instance, zinc phthalocyanine, a long-wavelength absorbing photosensitizer, is integrated into a polymeric nanoparticle core made of poly(D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol) (PLGA-b-PEG). The core's surface can be coated with metallic nanoparticles modified with CpG-ODN. In studies, metastatic mouse breast carcinoma cells exhibited significant photocytotoxicity after irradiation with a 660 nm LASER light, demonstrating that this hybrid approach is remarkably more effective than either treatment alone.
Career Highlights
Joshua Choi is affiliated with the University of Georgia Research Foundation Inc., where he continues to advance his research in nanoparticle technology and cancer treatment. His innovative approach has the potential to revolutionize how cancer is treated, providing new avenues for therapeutic interventions.
Collaborations
Joshua has collaborated with notable researchers, including Sean M Marrache and Shanta Dhar. These collaborations have further enriched his research and contributed to the development of his patented technologies.
Conclusion
Joshua Choi's work in developing immune-stimulating photoactive hybrid nanoparticles represents a significant advancement in cancer treatment. His innovative approach combines cutting-edge technology with a deep understanding of immunology, paving the way for more effective cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile